Page last updated: 2024-12-08

khellactone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

khellactone: isolated from roots of Angelica pupuraefolia; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
AngelicagenusA plant genus of the family Apiaceae.[MeSH]ApiaceaeA large plant family in the order Apiales, also known as Umbelliferae. Most are aromatic herbs with alternate, feather-divided leaves that are sheathed at the base. The flowers often form a conspicuous flat-topped umbel. Each small individual flower is usually bisexual, with five sepals, five petals, and an enlarged disk at the base of the style. The fruits are ridged and are composed of two parts that split open at maturity.[MeSH]

Cross-References

ID SourceID
PubMed CID253856
CHEMBL ID129702
CHEBI ID168011
MeSH IDM0511163

Synonyms (16)

Synonym
9,10-dihydroxy-8,8-dimethyl-2h,8h,9h,10h-pyrano[2,3-h]chromen-2-one
518-76-3
9,10-dihydroxy-8,8-dimethyl-9,10-dihydropyrano[2,3-]chromen-2-one
CHEBI:168011
NCI60_041702
(+/-)-cis-khellactone
9,10-dihydroxy-8,8-dimethyl-9,10-dihydropyrano[2,3-f]chromen-2-one
nsc77209
6-chromanacrylic acid,4,5-trihydroxy-2,2-dimethyl-, .delta.-lactone
nsc-77209
NCIOPEN2_003994
CHEMBL129702
khellactone
ncgc00384976-01!9,10-dihydroxy-8,8-dimethyl-9,10-dihydropyrano[2,3-f]chromen-2-one
ur04ok5s60 ,
unii-ur04ok5s60

Research Excerpts

Overview

Khellactone (3) is a major compound of the roots of A.

ExcerptReferenceRelevance
"Khellactone (3) is a major compound of the roots of A."( Isolation of coumarins and ferulate from the roots of Angelica purpuraefolia and the antitumor activity of khellactone.
Ahn, KS; Joung, H; Kim, JC; Kwon, OK; Lee, HK; Lee, J; Min, BS; Oh, SR, 2007
)
1.27

Treatment

ExcerptReferenceRelevance
"cis-Khellactone treatment specifically decreased dermal macrophage infiltration in psoriatic skin but not in neutrophils or T cells."( cis-Khellactone Inhibited the Proinflammatory Macrophages via Promoting Autophagy to Ameliorate Imiquimod-Induced Psoriasis.
Feng, L; Guo, M; Huang, W; Kong, L; Shao, F; Song, P; Wu, X; Xu, F; Xu, L; Xu, Q, 2019
)
1.55

Toxicity

ExcerptReferenceRelevance
" The aim of this work was to evaluate antidiabetic activity in Streptozotocin (STZ)-induced diabetic rats and the antioxidant effects of 3',4'-Di-O-acetyl-cis-khellactone (DOAcK), as well as its toxic potential."( Antidiabetic effect, antioxidant activity, and toxicity of 3',4'-Di-O-acetyl-cis-khellactone in Streptozotocin-induced diabetic rats.
Burgueño-Tapia, E; Cornejo-Garrido, J; Domínguez-Mendoza, EA; Ordaz-Pichardo, C, 2016
)
0.86

Pharmacokinetics

ExcerptReferenceRelevance
" Attention was mainly paid to the pharmacological features, therapeutic mechanisms and structure-activity relationships of KDs in previous reviews, whereas their pharmacokinetic and metabolic characteristics have seldom been discussed."( Pharmacokinetic and Metabolic Characteristics of Herb-Derived Khellactone Derivatives, A Class of Anti-HIV and Anti-Hypertensive: A Review.
Chang, C; Du, W; Fu, Q; Guo, P; Jing, W; Liu, R; Luo, Z; Zeng, A; Zhang, T, 2016
)
0.67
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
coumarins
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID79298Anti-HIV activity in acutely infected H9 lymphocytes.1994Journal of medicinal chemistry, Nov-11, Volume: 37, Issue:23
Anti-AIDS agents. 15. Synthesis and anti-HIV activity of dihydroseselins and related analogs.
AID79441Tested for in vitro therapeutic index as the ratio of IC50 to EC50 in acutely infected H9 Lymphocytes.1994Journal of medicinal chemistry, Nov-11, Volume: 37, Issue:23
Anti-AIDS agents. 15. Synthesis and anti-HIV activity of dihydroseselins and related analogs.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (4.55)18.2507
2000's4 (18.18)29.6817
2010's15 (68.18)24.3611
2020's2 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.55%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (95.45%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]